Article
14 Aug 2025
Health Care Marketing Enforcement: FTC Targets Telehealth Company For Deceptive Weight Loss Marketing Claims
RANKINGS
This author falls within the Top 20% for their listed topics and industry categories. Based on Mondaq users readership, this author is ranked as VERY POPULAR in United States
AUTHORS CONTENT
Article
18 Jul 2025
Gender-Affirming Care: Key Takeaways From FTC's July 2025 Workshop On Unfair Or Deceptive Trade Practices
Article
08 Jul 2025
Gender-Affirming Care: What The Supreme Court's Ruling In Skrmetti Means For Health Care Providers Nationwide
Article
16 May 2025
Data Transactions: DOJ's Final Rule's Implications For Academic Medical Centers With Clinical Research Programs
Article
07 Feb 2025
FDA & OHRP Draft Guidance: Including Tissue Biopsies In Clinical Trials
Article
28 Jan 2025
DEA Tightens Buprenorphine Telemedicine Prescribing Rules
Article
03 Jan 2025
Medicare Telehealth Flexibilities Get A Three-Month Lifeline
Article
23 Dec 2024
Private Equity: Senators Markey And Braun Seek Information On Role In Treatment For Opioid Use Disorder
Article
21 Nov 2024
FDA Clinical Investigations: New Guidance On Electronic Systems
Article
02 Aug 2024
Substance Use Disorder Treatment Services: 2025 Physician Fee Schedule Proposed Rule Would Expand Access And Medicare Coverage
Article
26 Jul 2024
Clinical Trials: FDA Publishes Draft Guidance On Diversity Action Plans
Article
09 May 2024
2024 Health Care & Life Sciences Top Trends - Driving Tomorrow's Advances In The Health Care And Life Sciences Ecosystems
Article
01 May 2024
New Favorable OIG Advisory Opinion Allows Patient Assistant Programs Funded By Drug Manufacturers
Article
19 Feb 2024
Opioid Treatment Programs: SAMHSA Makes Permanent Regulatory Flexibilities
Article
12 Feb 2024
Behavioral Health: CMS Innovation Model Outlines Changes For The Delivery Of Integrated Behavioral And Physical Health Care
Article
15 Nov 2023
CMS Expands Access To Behavioral Health Services; Physician Fee Schedule Expands Billing Providers And Flexibilities
Article
03 Nov 2023
FDA: New Draft Guidance On Communication Of Unapproved Uses Of Approved Or Cleared Medical Products
Article
01 Nov 2023
FDA's New Enforcement Policy: A Win For Remote Patient Monitoring And Remote Therapeutic Monitoring Manufacturers
Article
27 Oct 2023
FDA Issues New Warning Regarding Compounded Ketamine
Article
11 Sep 2023
Clinical Trials: Consent Process Clarified In New FDA Final Guidance